Cardiac Safety Services
Cambridge Bioscience represent Chantest throughout Europe. As a result, we are able to offer the most complete range of cardiac safety services.
Chantest’s Thorough Preclinical Safety Package (TSP) provides a comprehensive preclinical cardiac safety assessment for full resolution of potential cardiac risk prior to IND submission.
Multiple assays are employed to assess a compound’s effect on all cardiac ion channels at molecular, cellular and system levels. The TSP can also be used to resolve discordances between S7B recommended assays or issues identified during the clinical trial phase.
For an overview of the TSP visit Chantest’s website here where full details can be found. To discuss either a full TSP project, or any of the individual assays that comprise it, please contact us directly by email.